T cell targeting therapies – January 2021 T cell targeting therapies – January 2021 Harpoon Therapeutics received Orphan Drug Designation from FDA for HPN217 for treatment of multiple myeloma 13 Jan 2021 Harpoon Therapeutics – HPN217 (Anti-BCMA Tri specific T-cell […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id